| Nov 14 |
Biotech Stock Roundup: NVAX Q3 Results, SNDX Down on AML Data, RNA Surges on Study Data
|
| Nov 14 |
RNA Stock Hits Record High on Entering the Cardiac Disease Space
|
| Nov 13 |
Avidity Bio Has Surged 416% This Year — And That's Before Today's 'Game-Changing' News
|
| Nov 13 |
Avidity Biosciences jumps 16%; reaches all-time high
|
| Nov 12 |
Avidity Biosciences Announces New Precision Cardiology Development Candidates to Treat Rare Genetic Cardiomyopathies and Provides First Look at Next-Generation Technology Innovations
|
| Nov 9 |
Avidity Biosciences Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
|
| Nov 8 |
Avidity Biosciences reports Q3 results
|
| Nov 7 |
Avidity Biosciences, Inc. (RNA) Reports Q3 Loss, Lags Revenue Estimates
|
| Nov 7 |
Avidity Biosciences Reports Third Quarter 2024 Financial Results and Recent Highlights
|
| Nov 6 |
Analysts Estimate Avidity Biosciences, Inc. (RNA) to Report a Decline in Earnings: What to Look Out for
|
